Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between Two Different Doses of Intravenous Magnesium Sulfate for Prevention of Post-Spinal Shivering During Cesarean Section: A Double-Blind Randomized Clinical Trial

NCT07913828 is registered in ClinicalTrials.gov with Suez Canal University as lead sponsor.

NCT NCT07913828 Not yet recruiting Phase 4 82 participants (estimated) Started 2026 1 site

Follow this trial by email Email me the PDF

Get the NCT07913828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Summary

Not yet recruiting, started November 2026. Interventional study, Phase 4, 82 participants (estimated). Lead sponsor Suez Canal University; Egypt. Primary measure: Incidence of Clinically Significant Post-Spinal Shivering (Crossley-Mahajan Grade ≥3).

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between Two Different Doses of Intravenous Magnesium Sulfate for Prevention of Post-Spinal Shivering During Cesarean Section: A Double-Blind Randomized Clinical Trial
Lead sponsor
Suez Canal University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 2, 2026
Completion date
December 15, 2026
Enrollment
82 (estimated)
Sites
1

Conditions

As the registry lists them.

post spinal anesthesia shivering

Who could take part, where it ran, who ran it

As filed in ClinicalTrials.gov.

Sex
Female
Minimum age
18 Years
Maximum age
40 Years
Healthy volunteers
No
Study type
Interventional
Sites
1
Countries
Egypt
Lead sponsor
Suez Canal University

Arms

As registered; 2 arms.

Registered arms
Arm Type Interventions
Group A (Magnesium Sulfate 50 mg/kg) Experimental Magnesium Sulfate 50 mg/kg IV
Group B (Magnesium Sulfate 30 mg/kg) Active comparator Magnesium Sulfate 30 mg/kg IV

Primary endpoints

Registered primary outcome measures; 1 primary.

Registered primary endpoints
Measure Time frame
Incidence of Clinically Significant Post-Spinal Shivering (Crossley-Mahajan Grade ≥3) From immediately after spinal anesthesia until 60 minutes after spinal anesthesia

Lead sponsor's other trials

Suez Canal University, most recent start first.